Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Dữ liệu Lầu Năm Góc cho thấy hơn 200 binh sĩ Mỹ bị thương kể từ khi Mỹ nối lại giao tranh với Iran trong tháng 7

Dữ liệu Lầu Năm Góc cho thấy hơn 200 binh sĩ Mỹ bị thương kể từ khi Mỹ nối lại giao tranh với Iran trong tháng 7

Thế giới
(Baothanhhoa.vn) - Theo số liệu Bộ Quốc phòng Mỹ cập nhật ngày 26/7, hạng mục thống kê mới "Các chiến dịch ở nước ngoài" ghi nhận 4 quân nhân Mỹ thiệt mạng và 207 người bị thương kể từ ngày 7/7, thời điểm Washington xác định là bắt đầu vòng giao tranh mới với Iran.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh